IDegLira vs. Insulin Glargine: A Phase 3 Trial for Better Type 2 Diabetes Management
A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus
Study Design
Population
Patients with type 2 diabetes.
Intervention
IDegLira (insulin degludec/liraglutide combination).
Comparator
Insulin glargine.
Outcome
The primary endpoint was not specified in the provided digest.
Abstract
A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus. DUALTM IX - Add-on to SGLT2i
NCT ID:…